Food and Drug Regulations, C.R.C., c. 870
Section C.08.009.2
Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.08.009.2 · current to June 17, 2026 · regulation last amended June 17, 2026
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) Information in respect of a clinical trial that is confidential business information ceases to be confidential business information when one of the following circumstances occurs with respect to the submission or supplement:
(a) the Minister issues a notice of compliance under section C.08.004 or C.08.004.01;
(b) in the case where the Minister issues a notice to the manufacturer under paragraph C.08.004(1)(b) or C.08.004.01(1)(b) and the manufacturer does not amend the submission or supplement under subsection C.08.004(2) or C.08.004.01(2), the applicable period referred to in the relevant subsection expires;
(c) the Minister issues a notice to the manufacturer under paragraph C.08.004(3)(b) or C.08.004.01(3)(b).
(2) Subsection (1) does not apply to information in respect of a clinical trial that
(a) was not used by the manufacturer in the submission or supplement to support the proposed conditions of use for the new drug or the purpose for which the new drug is recommended; or
(b) describes tests, methods or assays that are used exclusively by the manufacturer.
Read the Food and Drug Regulations on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.